Averin

Averin is a healthcare-focused venture capital firm investing in companies transforming healthcare through technology and innovation. The firm identifies and partners with high-performance companies developing technologies in therapeutic platforms, diagnostics, predictive analytics, and personalized medicine, aiming to solve key market problems in healthcare. Averin primarily serves sectors including therapeutic development, diagnostic support, and integrated care platforms. Founded in 2023 and based in New York, New York, Averin focuses on early-stage investments, targeting seed, Series A, and Series B funding rounds. The firm has a global investment reach, including the United States, Middle East and North Africa, United Arab Emirates, and Saudi Arabia. Averin's investment strategy emphasizes companies at the intersection of data science, artificial intelligence, life sciences, and deep technology. Averin's investment approach is characterized by a blend of data-driven decision-making and strong sector expertise. The firm's strategic focus on emerging trends positions it as a prominent player in the venture capital landscape, with a track record of successful exits and a commitment to supporting companies that are transforming healthcare through technology and innovation.

Strong management teams, Scalable technologies, Significant market opportunities